Haloperidol

By

Generic Name: Haloperidol Brand Name(s): Generics only. No brands available. Avability: Rx Pregnancy Category: C

Uses

What is Haloperidol used for?

Haloperidol is used to treat certain mental/mood disorders (e.g., schizophrenia, schizoaffective disorders). This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can also help prevent suicide in people who are likely to harm themselves. It also reduces aggression and the desire to hurt others. It can decrease negative thoughts and hallucinations.

Haloperidol can also be used to treat uncontrolled movements and outbursts of words/sounds related to Tourette’s disorder. Haloperidol is also used for severe behavior problems in hyperactive children when other treatments or medications have not worked.

Haloperidol is a psychiatric medication (antipsychotic-type) that works by helping to restore the balance of certain natural substances in the brain (neurotransmitters).

How should I take Haloperidol?

Take this medication by mouth with or without food, or as directed by your doctor. If you are using the liquid form of the medication, use the measuring dropper provided in the package to measure your dose. If you do not have the dropper, ask your pharmacist for a measured oral syringe so that your dose will be correct.

Dosage is based on your medical condition and response to therapy. Use this medication regularly in order to get the most benefit from it. To help you remember, use it at the same time(s) each day.

Do not stop taking this medication without consulting your doctor. Some conditions may become worse when the drug is suddenly stopped. Your dose may need to be gradually reduced.

Inform your doctor if your symptoms do not improve or if they worsen.

How do I store Haloperidol?

Haloperidol is best stored at room temperature away from direct light and moisture. To prevent drug damage, you should not store Haloperidol in the bathroom or the freezer. There may be different brands of Haloperidol that may have different storage needs. It is important to always check the product package for instructions on storage, or ask your pharmacist. For safety, you should keep all medicines away from children and pets.

You should not flush Haloperidol down the toilet or pour them into a drain unless instructed to do so. It is important to properly discard this product when it is expired or no longer needed. Consult your pharmacist for more details about how to safely discard your product.

Precautions & warnings

What should I know before using Haloperidol?

Before taking haloperidol, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

Haloperidol may cause a condition that affects the heart rhythm (QT prolongation). QT prolongation can rarely cause serious (rarely fatal) fast/irregular heartbeat and other symptoms (such as severe dizziness, fainting) that need medical attention right away.

The risk of QT prolongation may be increased if you have certain medical conditions or are taking other drugs that may cause QT prolongation. Before using haloperidol, tell your doctor or pharmacist of all the drugs you take and if you have any of the following conditions: certain heart problems (heart failure, slow heartbeat, QT prolongation in the EKG), family history of certain heart problems (QT prolongation in the EKG, sudden cardiac death).

Low levels of potassium or magnesium in the blood may also increase your risk of QT prolongation. This risk may increase if you use certain drugs (such as diuretics/”water pills”) or if you have conditions such as severe sweating, diarrhea, or vomiting. Talk to your doctor about using haloperidol safely.

Before having surgery, be sure to tell your doctor or dentist that you are taking haloperidol.

This medication can reduce sweating, making you more likely to get heatstroke. Avoid hard work and exercise in hot weather.

Older adults may be more sensitive to the side effects of this drug, especially drowsiness, dizziness, lightheadedness, difficulty urinating, and heart effects such as QT prolongation (see above). Drowsiness, dizziness, and lightheadedness can increase the risk of falling.

During pregnancy, this medication should be used only when clearly needed. Babies born to mothers who have used this drug during the last 3 months of pregnancy may rarely develop symptoms including muscle stiffness or shakiness, drowsiness, feeding/breathing difficulties, or constant crying. If you notice any of these symptoms in your newborn especially during their first month, tell the doctor right away.

Since untreated mental/mood problems (such as schizophrenia, schizoaffective disorders) can be a serious condition, do not stop taking this medication unless directed by your doctor. If you are planning pregnancy, become pregnant, or think you may be pregnant, immediately discuss with your doctor the benefits and risks of using this medication during pregnancy.

This drug passes into breast milk and could have undesirable effects on a nursing infant. Consult your doctor before breast-feeding.

Is it safe during pregnancy or breast-feeding?

There are no adequate studies in women for determining risk when using this Haloperidol during pregnancy or while breastfeeding. Please always consult with your doctor to weigh the potential benefits and risks before taking Haloperidol. Haloperidol is pregnancy risk category C according to the US Food and Drug Administration (FDA).

FDA pregnancy risk category reference below:

  • A=No risk,
  • B=No risk in some studies,
  • C=There may be some risk,
  • D=Positive evidence of risk,
  • X=Contraindicated,
  • N=Unknown

Side effects

What side effects can occur from Haloperidol?

Dizziness, lightheadedness, drowsiness, difficulty urinating, sleep disturbances, headache, and anxiety may occur. If these effects persist or worsen, notify your doctor or pharmacist promptly.

Dizziness and lightheadedness can increase the risk of falling. Get up slowly when rising from a sitting or lying position.

Tell your doctor promptly if any of these side effects occur: muscle spasm/stiffness, shaking (tremor), restlessness, mask-like facial expression, drooling. Your doctor may prescribe another medication for you to take with haloperidol to decrease theseside effects.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

In rare cases, haloperidol may increase your level of a certain chemical made by the body (prolactin). For females, this increase in prolactin may result in unwanted breast milk, missed/stopped periods, or difficulty becoming pregnant. For males, it may result in decreased sexual ability, inability to produce sperm, or enlarged breasts. If you develop any of these symptoms, tell your doctor right away.

For males, in the unlikely event you have a painful or prolonged erection (lasting more than 4 hours), stop using this drug and seek immediate medical attention, or permanent problems may occur.

This medication may rarely cause a condition known as tardive dyskinesia. In some cases, this condition may be permanent. Tell your doctor right away if you develop any facial/muscle twitching such as tongue thrusting, chewing movements, puffing or puckering of your mouth, or uncontrollable shaking.

This medication may rarely cause a very serious condition called neuroleptic malignant syndrome (NMS). Get medical help right away if you have any of the following symptoms: fever, muscle stiffness/pain/tenderness/weakness, severe tiredness, severe confusion, sweating, fast/irregular heartbeat, dark urine, signs of kidney problems (such as change in the amount of urine).

Tell your doctor right away if any of these rare but very serious side effects occur: persistent nausea/vomiting, stomach/abdominal pain, yellowing of eyes/skin, seizures, signs of infection (such as fever, persistent sore throat).

Seek immediate medical attention if any of these rare but very serious side effects occur: slow heartbeat, severe dizziness, chest pain, fainting.

A very severe allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of an allergic reaction include: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

Not everyone experiences these side effects. There may be some side effects not listed above. If you have any concerns about a side-effect, please consult your doctor or pharmacist.

Interactions

What drugs may interact with Haloperidol?

Some products that may interact with this drug include: anticholinergic medications (e.g., antispasmodics such as belladonna alkaloids, scopolamine), cabergoline, ketoconazole, lithium, methyldopa, drugs for Parkinson’s disease (e.g., levodopa and carbidopa, selegiline), paroxetine, pergolide, quinupristin-dalfopristin, rifampin, saquinavir.

Many drugs besides haloperidol may affect the heart rhythm (QT prolongation), including amiodarone, dofetilide, pimozide, quinidine, sotalol, procainamide, macrolide antibiotics (such as erythromycin), among others. Therefore, before using haloperidol, report all medications you are currently using to your doctor or pharmacist.

Tell your doctor or pharmacist if you are taking other products that cause drowsiness such as opioid pain or cough relievers (such as codeine, hydrocodone), alcohol, marijuana, drugs for sleep or anxiety (such as alprazolam, lorazepam, zolpidem), muscle relaxants (such as carisoprodol, cyclobenzaprine), or antihistamines (such as cetirizine, diphenhydramine).

Check the labels on all your medicines (such as allergy or cough-and-cold products) because they may contain ingredients that cause drowsiness. Ask your pharmacist about using those products safely.

Haloperidol may interact with other drugs that you are currently taking, which can change how your drug works or increase your risk for serious side effects. To avoid any potential drug interactions, you should keep a list of all the drugs you are using (including prescription drugs, nonprescription drugs and herbal products) and share it with your doctor and pharmacist. For your safety, do not start, stop, or change the dosage of any drugs without your doctor’s approval.

Does food or alcohol interact with Haloperidol?

Haloperidol may interact with food or alcohol by altering the way the drug works or increase the risk for serious side effects. Please discuss with your doctor or pharmacist any potential food or alcohol interactions before using this drug.

This drug may make you dizzy or drowsy. Alcohol or marijuana can make you more dizzy or drowsy. Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Limit alcoholic beverages. Talk to your doctor if you are using marijuana.

What health conditions may interact with Haloperidol?

Haloperidol may interact with your health condition. This interaction may worsen your health condition or alter the way the drug works. It is important to always let your doctor and pharmacist know all the health conditions you currently have.

This medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have: a certain severe nervous system problem (severe CNS depression), Parkinson’s disease.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: bipolar disorder, difficulty urinating (e.g., due to prostate problems), glaucoma, heart problems (e.g., angina), overactive thyroid (hyperthyroidism), seizures, low white blood cell count.

Dosage

The information provided is not a substitute for any medical advice. You should ALWAYS consult with your doctor or pharmacist before using this Haloperidol.

What is the dose of Haloperidol for an adult?

Usual Adult Dose for Psychosis

Oral Haloperidol Formulations:

Moderate symptomology: 0.5 to 2 mg orally 2 to 3 times a day

Severe symptomology: 3 to 5 mg orally 2 to 3 times a day

-Initial doses of up to 100 mg/day have been necessary in some severely resistant cases.

Maintenance dose: After achieving a satisfactory response, the dose should be adjusted as practical to achieve optimum control

Haloperidol Lactate for Injection:

Prompt control acute agitation: 2 to 5 mg IM every 4 to 8 hours

-The frequency of IM administration should be determined by patient response and may be given as often as every hour.

Maximum dose: 20 mg/day

Comments:

-Oral formulations should be used as soon as practical.

-The total parenteral dose in the preceding 24 hours may be used to approximate an initial oral total daily dose. Initial oral doses should be given within 12 to 24 hours after the last parenteral dose.

-The safety of prolonged oral doses of 100 mg/day or greater has not been studied.

Haloperidol Decanoate for Injection:

Initial dose of-Maximum initial dose: 100 mg; if greater than 100 mg is needed, the dose should be administered in 2 separate injections (100 mg followed by the balance in 3 to 7 days)

Maintenance dose: 10 to 15 times the previous daily oral dose IM once a month, titrated to response

r patients stabilized on low daily oral doses (up to 10 mg/day): 10 to 15 times the daily oral dose IM once a month

Initial dose for patients stabilized on higher daily oral doses, tolerant to oral treatment, or at risk of relapse: 20 times the daily oral dose IM once a month

-Maximum initial dose: 100 mg; if greater than 100 mg is needed, the dose should be administered in 2 separate injections (100 mg followed by the balance in 3 to 7 days)

Maintenance dose: 10 to 15 times the previous daily oral dose IM once a month, titrated to response

-Maximum monthly dose: 450 mg

Comments:

-Patients should be stabilized on antipsychotic medication before starting prolonged parenteral therapy.

-Monitor closely during initiation and stabilization to minimize the risk of overdosage or reappearance of psychotic symptoms; short acting formulations may be used during this period of adjustment.

-Extended-release injections are generally administered once a month or every 4 weeks, however, the dosing interval as well as dose may be adjusted to best suit the patient.

-Clinical experience with doses greater than 450 mg per months is limited.

Uses:

-Treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy

-Management of manifestations of psychotic disorders

Usual Adult Dose for Schizophrenia

Oral Haloperidol Formulations:

Moderate symptomology: 0.5 to 2 mg orally 2 to 3 times a day

Severe symptomology: 3 to 5 mg orally 2 to 3 times a day

-Initial doses of up to 100 mg/day have been necessary in some severely resistant cases.

Maintenance dose: After achieving a satisfactory response, the dose should be adjusted as practical to achieve optimum control

Haloperidol Lactate for Injection:

Prompt control acute agitation: 2 to 5 mg IM every 4 to 8 hours

-The frequency of IM administration should be determined by patient response and may be given as often as every hour.

Maximum dose: 20 mg/day

Comments:

-Oral formulations should be used as soon as practical.

-The total parenteral dose in the preceding 24 hours may be used to approximate an initial oral total daily dose. Initial oral doses should be given within 12 to 24 hours after the last parenteral dose.

-The safety of prolonged oral doses of 100 mg/day or greater has not been studied.

Haloperidol Decanoate for Injection:

Initial dose of-Maximum initial dose: 100 mg; if greater than 100 mg is needed, the dose should be administered in 2 separate injections (100 mg followed by the balance in 3 to 7 days)

Maintenance dose: 10 to 15 times the previous daily oral dose IM once a month, titrated to response

r patients stabilized on low daily oral doses (up to 10 mg/day): 10 to 15 times the daily oral dose IM once a month

Initial dose for patients stabilized on higher daily oral doses, tolerant to oral treatment, or at risk of relapse: 20 times the daily oral dose IM once a month

-Maximum initial dose: 100 mg; if greater than 100 mg is needed, the dose should be administered in 2 separate injections (100 mg followed by the balance in 3 to 7 days)

Maintenance dose: 10 to 15 times the previous daily oral dose IM once a month, titrated to response

-Maximum monthly dose: 450 mg

Comments:

-Patients should be stabilized on antipsychotic medication before starting prolonged parenteral therapy.

-Monitor closely during initiation and stabilization to minimize the risk of overdosage or reappearance of psychotic symptoms; short acting formulations may be used during this period of adjustment.

-Extended-release injections are generally administered once a month or every 4 weeks, however, the dosing interval as well as dose may be adjusted to best suit the patient.

-Clinical experience with doses greater than 450 mg per months is limited.

Uses:

-Treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy

-Management of manifestations of psychotic disorders

Usual Adult Dose for Agitated State

Oral Haloperidol Formulations:

Moderate symptomology: 0.5 to 2 mg orally 2 to 3 times a day

Severe symptomology: 3 to 5 mg orally 2 to 3 times a day

-Initial doses of up to 100 mg/day have been necessary in some severely resistant cases.

Maintenance dose: After achieving a satisfactory response, the dose should be adjusted as practical to achieve optimum control

Haloperidol Lactate for Injection:

Prompt control acute agitation: 2 to 5 mg IM every 4 to 8 hours

-The frequency of IM administration should be determined by patient response and may be given as often as every hour.

Maximum dose: 20 mg/day

Comments:

-Oral formulations should be used as soon as practical.

-The total parenteral dose in the preceding 24 hours may be used to approximate an initial oral total daily dose. Initial oral doses should be given within 12 to 24 hours after the last parenteral dose.

-The safety of prolonged oral doses of 100 mg/day or greater has not been studied.

Uses:

-Management of manifestations of psychotic disorders

-Prompt control of acute agitation in patients with schizophrenia with moderately severe to severe symptoms

Usual Adult Dose for Agitation

Oral Haloperidol Formulations:

Moderate symptomology: 0.5 to 2 mg orally 2 to 3 times a day

Severe symptomology: 3 to 5 mg orally 2 to 3 times a day

-Initial doses of up to 100 mg/day have been necessary in some severely resistant cases.

Maintenance dose: After achieving a satisfactory response, the dose should be adjusted as practical to achieve optimum control

Haloperidol Lactate for Injection:

Prompt control acute agitation: 2 to 5 mg IM every 4 to 8 hours

-The frequency of IM administration should be determined by patient response and may be given as often as every hour.

Maximum dose: 20 mg/day

Comments:

-Oral formulations should be used as soon as practical.

-The total parenteral dose in the preceding 24 hours may be used to approximate an initial oral total daily dose. Initial oral doses should be given within 12 to 24 hours after the last parenteral dose.

-The safety of prolonged oral doses of 100 mg/day or greater has not been studied.

Uses:

-Management of manifestations of psychotic disorders

-Prompt control of acute agitation in patients with schizophrenia with moderately severe to severe symptoms

Usual Adult Dose for Tourette’s Syndrome

Oral Haloperidol Formulations:

Initial dose:

-Moderate symptomology: 0.5 to 2 mg orally 2 to 3 times a day

-Severe symptomology: 3 to 5 mg orally 2 to 3 times a day

Maintenance dose: After achieving a satisfactory response, the dose should be adjusted as practical to achieve optimum control

Haloperidol Lactate for Injection:

Prompt control acute agitation: 2 to 5 mg IM every 4 to 8 hours

-The frequency of IM administration should be determined by patient response and may be given as often as every hour.

Maximum dose: 20 mg/day

Comments:

-Oral formulations should be used as soon as practical.

-The total parenteral dose in the preceding 24 hours may be used to approximate an initial oral total daily dose. Initial oral doses should be given within 12 to 24 hours after the last parenteral dose.

-The safety of prolonged oral doses of 100 mg/day or greater has not been studied.

-Patients with chronic/resistant cases should be given the severe symptom dose.

Use:

-Control of tics and vocal utterances of Tourette’s disorder

Usual Geriatric Dose for Schizophrenia

Oral Haloperidol Formulations:

Moderate symptomology: 0.5 to 2 mg orally 2 to 3 times a day

Severe symptomology: 3 to 5 mg orally 2 to 3 times a day

-Initial doses of up to 100 mg/day have been necessary in some severely resistant cases.

Maintenance dose: After achieving a satisfactory response, the dose should be adjusted as practical to achieve optimum control

Haloperidol Lactate for Injection:

-Recommended dose: 2 to 5 mg IM every 4 to 8 hours

-The frequency of IM administration should be determined by patient response and may be given as often as every hour.

-Maximum dose: 20 mg/day

Comments:

-Oral formulations should be used as soon as practical.

-The total parenteral dose in the preceding 24 hours may be used to approximate an initial oral total daily dose. Initial oral doses should be given within 12 to 24 hours after the last parenteral dose.

-The safety of prolonged oral doses of 100 mg/day or greater has not been studied.

Haloperidol Decanoate for Injection:

-Initial dose: 10 to 15 times the daily oral dose IM once

-Maintenance dose: 10 to 15 times the previous daily oral dose IM once a month

-Maximum initial dose: 100 mg; if greater than 100 mg is needed, the dose should be administered in 2 separate injections (100 mg followed by the balance in 3 to 7 days)

-Maximum monthly dose: 450 mg

Comments:

-Patients should be stabilized on antipsychotic medication before starting prolonged parenteral therapy.

-Monitor closely during initiation and stabilization to minimize the risk of overdosage or reappearance of psychotic symptoms; short acting formulations may be used during this period of adjustment.

-Extended-release injections are generally administered once a month or every 4 weeks, however, the dosing interval as well as dose may be adjusted to best suit the patient.

-Clinical experience with doses greater than 450 mg per months is limited.

Uses:

-Treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy

-Treatment of schizophrenia

Dose Adjustments

Switchover Procedure:

-Initial oral daily doses should be determined by the total 24 hour parenteral dose.

-The first oral dose should be given 12 to 24 hours after the last parenteral dose.

-Patients should be monitored for sedation and/or adverse events periodically for the first few days of oral therapy; dose adjustments may be required based on patient response.

Debilitated patients: Lower initial doses recommended in geriatric dosing should be considered.

Other Comments

Administration advice:

-IM formulations should be administered with the Z-track method to prevent leakage from the injection site.

-Haloperidol decanoate for injection should only be administered via deep intramuscular route, preferably into the gluteal region. Injection volumes should not exceed 3 mL.

-Oral solution: Administer with a calibrated dropper.

Storage requirements:

-Protect from light and store at room temperature.

Reconstitution/preparation techniques:

-See manufacturer product information.

General:

-Treatment should be periodically reevaluated to ensure that the lowest possible effective dose is used.

-There is considerable variability in the amount of medication needed to achieve optimum levels.

-Haloperidol decanoate for injection may be given as one-half of the monthly dose IM every 2 weeks in specific patients or situations.

Monitoring:

-Periodic WBC with differential tests, especially in patients with signs/symptoms of infection/sore throat or with a history of low WBCs or drug-induced neutropenia/leukopenia

-Periodic liver function tests, with increased frequency in patients with signs/symptoms of liver impairment

-Blood pressure, especially in patients with impaired cardiovascular systems

-Eye examinations, especially in patients on prolonged treatment

-Periodic electrolyte levels, especially in patients with a high risk of developing cardiovascular events and/or those taking diuretics

-Routine weight, blood glucose, hemoglobin A1C

Patient advice:

-Warn patients to avoid abrupt discontinuation of this drug.

-Tell patients to immediately report any signs/symptoms of neutropenia/leukopenia, neuroleptic malignant syndrome, or tardive dyskinesia.

-Advise patients, and families/caregivers to monitor and report signs/symptoms of unusual behavior immediately to their healthcare provider (e.g., agitation, irritability, anxiety, panic attacks, insomnia, hostility, aggressiveness, impulsivity, akathisia, hypomania/mania).

-Patients should be advised to report all concurrent prescription and nonprescription medications or herbal products they are taking.

-Patients should be advised to speak to a healthcare provider if they are pregnant, intend to become pregnant, or are breastfeeding.

-Inform patients that this drug may cause drowsiness, and they should avoid driving or operating machinery until the full effects of the drug are seen.

What is the dose of Haloperidol for a child?

Usual Pediatric Dose for Psychosis

3 to 12 years and 15 to 40 kg:

Initial dose: 0.5 mg/day orally in 2 to 3 divided doses

-Adjust in increments of 0.5 mg every 5 to 7 days until desired effect is achieved

Maintenance dose: 0.05 to 0.15 mg/kg/day in 2 to 3 divided doses

13 years and older and greater than 40 kg:

Initial dose:

-Moderate symptomology: 0.5 to 2 mg orally 2 to 3 times a day

-Severe symptomology: 3 to 5 mg orally 2 to 3 times a day

Maintenance dose: After achieving a satisfactory response, the dose should be adjusted as practical to achieve optimum control

Comment:

-Severely disturbed patients may require higher doses.

Use:

-Management of manifestations of psychotic disorders

Usual Pediatric Dose for Tourette’s Syndrome

3 to 12 years and 15 to 40 kg:

-Initial dose: 0.5 mg/day orally in 2 to 3 divided doses

-Maintenance dose: 0.05 to 0.075 mg/kg/day

13 years and older and greater than 40 kg

Initial dose:

-Moderate symptomology: 0.5 to 2 mg orally 2 to 3 times a day

-Severe symptomology: 3 to 5 mg orally 2 to 3 times a day

Maintenance dose: After achieving a satisfactory response, the dose should be adjusted as practical to achieve optimum control

Comment:

-The daily dose may be increased every 5 to 7 days in 0.5 mg increments in patients 3 to 12 years of age and 15 to 40 kg.

Use:

-Control of tics and vocal utterances of Tourette’s disorder

Usual Pediatric Dose for Agitated State

3 to 12 years and 15 to 40 kg:

-Initial dose: 0.5 mg/day orally in 2 to 3 divided doses

-Maintenance dose: 0.05 to 0.075 mg/kg/day

Comments:

-The daily dose may be increased every 5 to 7 days in 0.5 mg increments.

-There is little evidence that behavior improvement is further enhanced by doses greater than 6 mg/day.

-Limitation of use: Treatment should be reserved for patients with severe behavior problems and/or hyperactive children only after failure to respond to psychotherapy or medications (other than antipsychotics).

Uses:

-Treatment of severe behavior problems in children, including combative, explosive hyperexcitability not accounted for by immediate provocation

-Short-term treatment of hyperactive children with excessive motor activity and accompanying conduct disorder with impulsivity, difficulty sustaining attention, aggressiveness, mood lability, and/or poor frustration tolerance.

Usual Pediatric Dose for Aggressive Behavior

3 to 12 years and 15 to 40 kg:

-Initial dose: 0.5 mg/day orally in 2 to 3 divided doses

-Maintenance dose: 0.05 to 0.075 mg/kg/day

Comments:

-The daily dose may be increased every 5 to 7 days in 0.5 mg increments.

-There is little evidence that behavior improvement is further enhanced by doses greater than 6 mg/day.

-Limitation of use: Treatment should be reserved for patients with severe behavior problems and/or hyperactive children only after failure to respond to psychotherapy or medications (other than antipsychotics).

Uses:

-Treatment of severe behavior problems in children, including combative, explosive hyperexcitability not accounted for by immediate provocation

-Short-term treatment of hyperactive children with excessive motor activity and accompanying conduct disorder with impulsivity, difficulty sustaining attention, aggressiveness, mood lability, and/or poor frustration tolerance.

Precautions

Safety and efficacy of oral formulations have not been established in patients younger than 3 years. Parenteral formulations are not recommended for use in children.

How is Haloperidol available?

Haloperidol is available in the following dosage forms and strengths:

  • Oral tablet,
  • Oral concentrate,
  • Intramuscular solution,
  • Injectable solution,
  • Compounding powder.

What should I do in case of an emergency or overdose?

In case of an emergency or an overdose, call your local emergency services or go to your nearest emergency room.

What should I do if I miss a dose?

If you miss a dose of Haloperidol, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and take your regular dose as scheduled. Do not take a double dose.

Hello Health Group does not provide medical advice, diagnosis or treatment.

Sources

Review Date: August 9, 2018 | Last Modified: August 9, 2018

You might also like